Speech Biomarker Improves Schizophrenia Drug Trials, Reducing Costs and Boosting Efficacy

Speech Biomarker Improves Schizophrenia Drug Trials, Reducing Costs and Boosting Efficacy | Elsevier News (Feb 2026)